![Investigators' sense of failure thwarted transparency in clinical trials discontinued for poor recruitment - Journal of Clinical Epidemiology Investigators' sense of failure thwarted transparency in clinical trials discontinued for poor recruitment - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f491378e-37cf-407c-bf60-a45d64bb717c/gr1_lrg.jpg)
Investigators' sense of failure thwarted transparency in clinical trials discontinued for poor recruitment - Journal of Clinical Epidemiology
![NIH Issues Clinical Trial Transparency Proposal; Expands Submissions to Results From Unapproved Products, Requires Detailed Adverse Event Information – Policy & Medicine NIH Issues Clinical Trial Transparency Proposal; Expands Submissions to Results From Unapproved Products, Requires Detailed Adverse Event Information – Policy & Medicine](https://www.policymed.com/wp-content/uploads/2014/11/6a00e5520572bb883401b7c70a679b970b-800wi.png)
NIH Issues Clinical Trial Transparency Proposal; Expands Submissions to Results From Unapproved Products, Requires Detailed Adverse Event Information – Policy & Medicine
![Clinical Trial Transparency: Ensuring Compliance with the New FDA Guidelines | BrackenData Clinical Trial Intelligence Clinical Trial Transparency: Ensuring Compliance with the New FDA Guidelines | BrackenData Clinical Trial Intelligence](https://images.squarespace-cdn.com/content/v1/554a4b22e4b0feee68e3f1d0/1541732445009-FBOB5PG0QA3XNS8DOL28/shutterstock_1024337068.jpg?format=1000w)
Clinical Trial Transparency: Ensuring Compliance with the New FDA Guidelines | BrackenData Clinical Trial Intelligence
![Are the new clinical trial transparency rules incompatible with the patentability requirements in Europe? | Nature Biotechnology Are the new clinical trial transparency rules incompatible with the patentability requirements in Europe? | Nature Biotechnology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnbt.4265/MediaObjects/41587_2018_Article_BFnbt4265_Fig1_HTML.jpg)